Reports

Industry Research Reports

Global Pharmaceutical Grade Aluminum Hydroxide Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Pharmaceutical Grade Aluminum Hydroxide Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-08-05

Pages: 191 Pages

Report ld: 4874824

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Pharmaceutical Grade Aluminum Hydroxide market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Pharmaceutical grade aluminum hydroxide refers to aluminum hydroxide products that meet the relevant standards and requirements of the pharmaceutical industry. It is mainly used in the pharmaceutical field and is usually required to have high purity, no impurities, no toxic side effects, etc. to ensure safe and effective use in drug production and medical fields.

From a downstream perspective, Antacid Medication accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Pharmaceutical Grade Aluminum Hydroxide leading manufacturers including CHALCO, KC Corp, Sumitomo Chemicals, Zibo Pengfeng, Jianzhan Aluminium, AL-TECH, Nippon Light Metal, PT INDONESIA CHEMICAL ALUMINA, Huber, Nabaltec, etc., dominate supply; the top five capture approximately % of global revenue, with CHALCO leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceutical Grade Aluminum Hydroxide market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • CHALCO
  • KC Corp
  • Sumitomo Chemicals
  • Zibo Pengfeng
  • Jianzhan Aluminium
  • AL-TECH
  • Nippon Light Metal
  • PT INDONESIA CHEMICAL ALUMINA
  • Huber
  • Nabaltec
  • Inotal Aluminium
  • R.J. Marshall
  • Dadco Group
  • Alteo
  • Albemarle
  • Almatis
  • Showa Denko
  • Shandong Lvye
  • Luoyang Zhongchao Non-metallic
  • Zibo Peng Feng Aluminum
  • Shanxi Aluminum Big Plant Chemical
  • Zibo Hongjia Aluminum
  • Guangzhou Hengbang Chemical
  • Sichuan Chunfei Chemical

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Aluminum Hydroxide for Coating
  • Aluminum Hydroxide for Injection

Segment by Application

  • Antacid Medication
  • Anti-Gastric Ulcer Drugs
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the Pharmaceutical Grade Aluminum Hydroxide study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

marn_i1

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

marn_i1

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

marn_i1

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

marn_i1

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

marn_i1

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

marn_i1

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

marn_i1

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to Pharmaceutical Grade Aluminum Hydroxide: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Pharmaceutical Grade Aluminum Hydroxide Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Aluminum Hydroxide for Coating

1.2.3 Aluminum Hydroxide for Injection

1.3 Market Segmentation by Application

1.3.1 Global Pharmaceutical Grade Aluminum Hydroxide Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Antacid Medication

1.3.3 Anti-Gastric Ulcer Drugs

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Pharmaceutical Grade Aluminum Hydroxide Revenue Estimates and Forecasts 2020-2031

2.2 Global Pharmaceutical Grade Aluminum Hydroxide Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Pharmaceutical Grade Aluminum Hydroxide Sales Estimates and Forecasts 2020-2031

2.4 Global Pharmaceutical Grade Aluminum Hydroxide Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

muLu

3 Global Production Analysis

3.1 Global Pharmaceutical Grade Aluminum Hydroxide Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

muLu

4 Competition by Manufacturers

4.1 Global Pharmaceutical Grade Aluminum Hydroxide Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Pharmaceutical Grade Aluminum Hydroxide Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Aluminum Hydroxide for Coating Market Size by Manufacturers

4.5.2 Aluminum Hydroxide for Injection Market Size by Manufacturers

4.6 Global Pharmaceutical Grade Aluminum Hydroxide Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

muLu

5 Global Product Segmentation Analysis

5.1 Global Pharmaceutical Grade Aluminum Hydroxide Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Pharmaceutical Grade Aluminum Hydroxide Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

muLu

6 Global Downstream Application Analysis

6.1 Global Pharmaceutical Grade Aluminum Hydroxide Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Pharmaceutical Grade Aluminum Hydroxide Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

muLu

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Pharmaceutical Grade Aluminum Hydroxide Sales and Revenue by Type (2020-2031)

7.4 North America Pharmaceutical Grade Aluminum Hydroxide Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Pharmaceutical Grade Aluminum Hydroxide Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

muLu

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Pharmaceutical Grade Aluminum Hydroxide Sales and Revenue by Type (2020-2031)

8.4 Europe Pharmaceutical Grade Aluminum Hydroxide Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Pharmaceutical Grade Aluminum Hydroxide Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

muLu

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Pharmaceutical Grade Aluminum Hydroxide Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Pharmaceutical Grade Aluminum Hydroxide Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Pharmaceutical Grade Aluminum Hydroxide Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

muLu

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Pharmaceutical Grade Aluminum Hydroxide Sales and Revenue by Type (2020-2031)

10.4 Central and South America Pharmaceutical Grade Aluminum Hydroxide Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Pharmaceutical Grade Aluminum Hydroxide Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

muLu

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Pharmaceutical Grade Aluminum Hydroxide Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Pharmaceutical Grade Aluminum Hydroxide Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Pharmaceutical Grade Aluminum Hydroxide Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

muLu

12 Corporate Profile

12.1 CHALCO

12.1.1 CHALCO Corporation Information

12.1.2 CHALCO Business Overview

12.1.3 CHALCO Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.1.4 CHALCO Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 CHALCO Pharmaceutical Grade Aluminum Hydroxide Sales by Product in 2024

12.1.6 CHALCO Pharmaceutical Grade Aluminum Hydroxide Sales by Application in 2024

12.1.7 CHALCO Pharmaceutical Grade Aluminum Hydroxide Sales by Geographic Area in 2024

12.1.8 CHALCO Pharmaceutical Grade Aluminum Hydroxide SWOT Analysis

12.1.9 CHALCO Recent Developments

12.2 KC Corp

12.2.1 KC Corp Corporation Information

12.2.2 KC Corp Business Overview

12.2.3 KC Corp Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.2.4 KC Corp Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 KC Corp Pharmaceutical Grade Aluminum Hydroxide Sales by Product in 2024

12.2.6 KC Corp Pharmaceutical Grade Aluminum Hydroxide Sales by Application in 2024

12.2.7 KC Corp Pharmaceutical Grade Aluminum Hydroxide Sales by Geographic Area in 2024

12.2.8 KC Corp Pharmaceutical Grade Aluminum Hydroxide SWOT Analysis

12.2.9 KC Corp Recent Developments

12.3 Sumitomo Chemicals

12.3.1 Sumitomo Chemicals Corporation Information

12.3.2 Sumitomo Chemicals Business Overview

12.3.3 Sumitomo Chemicals Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.3.4 Sumitomo Chemicals Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Sumitomo Chemicals Pharmaceutical Grade Aluminum Hydroxide Sales by Product in 2024

12.3.6 Sumitomo Chemicals Pharmaceutical Grade Aluminum Hydroxide Sales by Application in 2024

12.3.7 Sumitomo Chemicals Pharmaceutical Grade Aluminum Hydroxide Sales by Geographic Area in 2024

12.3.8 Sumitomo Chemicals Pharmaceutical Grade Aluminum Hydroxide SWOT Analysis

12.3.9 Sumitomo Chemicals Recent Developments

12.4 Zibo Pengfeng

12.4.1 Zibo Pengfeng Corporation Information

12.4.2 Zibo Pengfeng Business Overview

12.4.3 Zibo Pengfeng Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.4.4 Zibo Pengfeng Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Zibo Pengfeng Pharmaceutical Grade Aluminum Hydroxide Sales by Product in 2024

12.4.6 Zibo Pengfeng Pharmaceutical Grade Aluminum Hydroxide Sales by Application in 2024

12.4.7 Zibo Pengfeng Pharmaceutical Grade Aluminum Hydroxide Sales by Geographic Area in 2024

12.4.8 Zibo Pengfeng Pharmaceutical Grade Aluminum Hydroxide SWOT Analysis

12.4.9 Zibo Pengfeng Recent Developments

12.5 Jianzhan Aluminium

12.5.1 Jianzhan Aluminium Corporation Information

12.5.2 Jianzhan Aluminium Business Overview

12.5.3 Jianzhan Aluminium Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.5.4 Jianzhan Aluminium Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Jianzhan Aluminium Pharmaceutical Grade Aluminum Hydroxide Sales by Product in 2024

12.5.6 Jianzhan Aluminium Pharmaceutical Grade Aluminum Hydroxide Sales by Application in 2024

12.5.7 Jianzhan Aluminium Pharmaceutical Grade Aluminum Hydroxide Sales by Geographic Area in 2024

12.5.8 Jianzhan Aluminium Pharmaceutical Grade Aluminum Hydroxide SWOT Analysis

12.5.9 Jianzhan Aluminium Recent Developments

12.6 AL-TECH

12.6.1 AL-TECH Corporation Information

12.6.2 AL-TECH Business Overview

12.6.3 AL-TECH Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.6.4 AL-TECH Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 AL-TECH Recent Developments

12.7 Nippon Light Metal

12.7.1 Nippon Light Metal Corporation Information

12.7.2 Nippon Light Metal Business Overview

12.7.3 Nippon Light Metal Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.7.4 Nippon Light Metal Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Nippon Light Metal Recent Developments

12.8 PT INDONESIA CHEMICAL ALUMINA

12.8.1 PT INDONESIA CHEMICAL ALUMINA Corporation Information

12.8.2 PT INDONESIA CHEMICAL ALUMINA Business Overview

12.8.3 PT INDONESIA CHEMICAL ALUMINA Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.8.4 PT INDONESIA CHEMICAL ALUMINA Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 PT INDONESIA CHEMICAL ALUMINA Recent Developments

12.9 Huber

12.9.1 Huber Corporation Information

12.9.2 Huber Business Overview

12.9.3 Huber Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.9.4 Huber Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Huber Recent Developments

12.10 Nabaltec

12.10.1 Nabaltec Corporation Information

12.10.2 Nabaltec Business Overview

12.10.3 Nabaltec Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.10.4 Nabaltec Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 Nabaltec Recent Developments

12.11 Inotal Aluminium

12.11.1 Inotal Aluminium Corporation Information

12.11.2 Inotal Aluminium Business Overview

12.11.3 Inotal Aluminium Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.11.4 Inotal Aluminium Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.11.5 Inotal Aluminium Recent Developments

12.12 R.J. Marshall

12.12.1 R.J. Marshall Corporation Information

12.12.2 R.J. Marshall Business Overview

12.12.3 R.J. Marshall Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.12.4 R.J. Marshall Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.12.5 R.J. Marshall Recent Developments

12.13 Dadco Group

12.13.1 Dadco Group Corporation Information

12.13.2 Dadco Group Business Overview

12.13.3 Dadco Group Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.13.4 Dadco Group Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.13.5 Dadco Group Recent Developments

12.14 Alteo

12.14.1 Alteo Corporation Information

12.14.2 Alteo Business Overview

12.14.3 Alteo Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.14.4 Alteo Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.14.5 Alteo Recent Developments

12.15 Albemarle

12.15.1 Albemarle Corporation Information

12.15.2 Albemarle Business Overview

12.15.3 Albemarle Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.15.4 Albemarle Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.15.5 Albemarle Recent Developments

12.16 Almatis

12.16.1 Almatis Corporation Information

12.16.2 Almatis Business Overview

12.16.3 Almatis Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.16.4 Almatis Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.16.5 Almatis Recent Developments

12.17 Showa Denko

12.17.1 Showa Denko Corporation Information

12.17.2 Showa Denko Business Overview

12.17.3 Showa Denko Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.17.4 Showa Denko Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.17.5 Showa Denko Recent Developments

12.18 Shandong Lvye

12.18.1 Shandong Lvye Corporation Information

12.18.2 Shandong Lvye Business Overview

12.18.3 Shandong Lvye Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.18.4 Shandong Lvye Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.18.5 Shandong Lvye Recent Developments

12.19 Luoyang Zhongchao Non-metallic

12.19.1 Luoyang Zhongchao Non-metallic Corporation Information

12.19.2 Luoyang Zhongchao Non-metallic Business Overview

12.19.3 Luoyang Zhongchao Non-metallic Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.19.4 Luoyang Zhongchao Non-metallic Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.19.5 Luoyang Zhongchao Non-metallic Recent Developments

12.20 Zibo Peng Feng Aluminum

12.20.1 Zibo Peng Feng Aluminum Corporation Information

12.20.2 Zibo Peng Feng Aluminum Business Overview

12.20.3 Zibo Peng Feng Aluminum Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.20.4 Zibo Peng Feng Aluminum Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.20.5 Zibo Peng Feng Aluminum Recent Developments

12.21 Shanxi Aluminum Big Plant Chemical

12.21.1 Shanxi Aluminum Big Plant Chemical Corporation Information

12.21.2 Shanxi Aluminum Big Plant Chemical Business Overview

12.21.3 Shanxi Aluminum Big Plant Chemical Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.21.4 Shanxi Aluminum Big Plant Chemical Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.21.5 Shanxi Aluminum Big Plant Chemical Recent Developments

12.22 Zibo Hongjia Aluminum

12.22.1 Zibo Hongjia Aluminum Corporation Information

12.22.2 Zibo Hongjia Aluminum Business Overview

12.22.3 Zibo Hongjia Aluminum Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.22.4 Zibo Hongjia Aluminum Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.22.5 Zibo Hongjia Aluminum Recent Developments

12.23 Guangzhou Hengbang Chemical

12.23.1 Guangzhou Hengbang Chemical Corporation Information

12.23.2 Guangzhou Hengbang Chemical Business Overview

12.23.3 Guangzhou Hengbang Chemical Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.23.4 Guangzhou Hengbang Chemical Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.23.5 Guangzhou Hengbang Chemical Recent Developments

12.24 Sichuan Chunfei Chemical

12.24.1 Sichuan Chunfei Chemical Corporation Information

12.24.2 Sichuan Chunfei Chemical Business Overview

12.24.3 Sichuan Chunfei Chemical Pharmaceutical Grade Aluminum Hydroxide Product Models, Descriptions and Specifications

12.24.4 Sichuan Chunfei Chemical Pharmaceutical Grade Aluminum Hydroxide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.24.5 Sichuan Chunfei Chemical Recent Developments

muLu

13 Value Chain and Supply-Chain Analysis

13.1 Pharmaceutical Grade Aluminum Hydroxide Industry Chain

13.2 Pharmaceutical Grade Aluminum Hydroxide Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Pharmaceutical Grade Aluminum Hydroxide Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Pharmaceutical Grade Aluminum Hydroxide Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

muLu

14 Pharmaceutical Grade Aluminum Hydroxide Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

muLu

15 Key Findings in the Global Pharmaceutical Grade Aluminum Hydroxide Study

muLu

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Pharmaceutical Grade Aluminum Hydroxide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pharmaceutical Grade Aluminum Hydroxide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pharmaceutical Grade Aluminum Hydroxide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pharmaceutical Grade Aluminum Hydroxide Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pharmaceutical Grade Aluminum Hydroxide Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Pharmaceutical Grade Aluminum Hydroxide Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Pharmaceutical Grade Aluminum Hydroxide Sales by Region (2020-2025) & (Tons)
Table 8. Global Pharmaceutical Grade Aluminum Hydroxide Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Pharmaceutical Grade Aluminum Hydroxide Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Pharmaceutical Grade Aluminum Hydroxide Production by Region (2020-2025) & (Tons)
Table 12. Global Pharmaceutical Grade Aluminum Hydroxide Production by Region (2026-2031) & (Tons)
Table 13. Global Pharmaceutical Grade Aluminum Hydroxide Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Pharmaceutical Grade Aluminum Hydroxide Sales Share by Manufacturers (2020-2025)
Table 15. Global Pharmaceutical Grade Aluminum Hydroxide Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Pharmaceutical Grade Aluminum Hydroxide Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Pharmaceutical Grade Aluminum Hydroxide by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Aluminum Hydroxide as of 2024)
Table 19. Global Pharmaceutical Grade Aluminum Hydroxide Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Pharmaceutical Grade Aluminum Hydroxide Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Pharmaceutical Grade Aluminum Hydroxide Manufacturing Base and Headquarters
Table 22. Global Pharmaceutical Grade Aluminum Hydroxide Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Pharmaceutical Grade Aluminum Hydroxide Sales by Type (2020-2025) & (Tons)
Table 26. Global Pharmaceutical Grade Aluminum Hydroxide Sales by Type (2026-2031) & (Tons)
Table 27. Global Pharmaceutical Grade Aluminum Hydroxide Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Pharmaceutical Grade Aluminum Hydroxide Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Pharmaceutical Grade Aluminum Hydroxide ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Pharmaceutical Grade Aluminum Hydroxide Sales by Application (2020-2025) & (Tons)
Table 32. Global Pharmaceutical Grade Aluminum Hydroxide Sales by Application (2026-2031) & (Tons)
Table 33. Pharmaceutical Grade Aluminum Hydroxide High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Pharmaceutical Grade Aluminum Hydroxide Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Pharmaceutical Grade Aluminum Hydroxide Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Pharmaceutical Grade Aluminum Hydroxide ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Pharmaceutical Grade Aluminum Hydroxide Growth Accelerators and Market Barriers
Table 40. North America Pharmaceutical Grade Aluminum Hydroxide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Pharmaceutical Grade Aluminum Hydroxide Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Pharmaceutical Grade Aluminum Hydroxide Growth Accelerators and Market Barriers
Table 43. Europe Pharmaceutical Grade Aluminum Hydroxide Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Pharmaceutical Grade Aluminum Hydroxide Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Pharmaceutical Grade Aluminum Hydroxide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Pharmaceutical Grade Aluminum Hydroxide Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Pharmaceutical Grade Aluminum Hydroxide Growth Accelerators and Market Barriers
Table 48. Southeast Asia Pharmaceutical Grade Aluminum Hydroxide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Pharmaceutical Grade Aluminum Hydroxide Investment Opportunities and Key Challenges
Table 50. Central and South America Pharmaceutical Grade Aluminum Hydroxide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Pharmaceutical Grade Aluminum Hydroxide Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Pharmaceutical Grade Aluminum Hydroxide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. CHALCO Corporation Information
Table 54. CHALCO Description and Major Businesses
Table 55. CHALCO Product Models, Descriptions and Specifications
Table 56. CHALCO Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. CHALCO Sales Value Proportion by Product in 2024
Table 58. CHALCO Sales Value Proportion by Application in 2024
Table 59. CHALCO Sales Value Proportion by Geographic Area in 2024
Table 60. CHALCO Pharmaceutical Grade Aluminum Hydroxide SWOT Analysis
Table 61. CHALCO Recent Developments
Table 62. KC Corp Corporation Information
Table 63. KC Corp Description and Major Businesses
Table 64. KC Corp Product Models, Descriptions and Specifications
Table 65. KC Corp Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. KC Corp Sales Value Proportion by Product in 2024
Table 67. KC Corp Sales Value Proportion by Application in 2024
Table 68. KC Corp Sales Value Proportion by Geographic Area in 2024
Table 69. KC Corp Pharmaceutical Grade Aluminum Hydroxide SWOT Analysis
Table 70. KC Corp Recent Developments
Table 71. Sumitomo Chemicals Corporation Information
Table 72. Sumitomo Chemicals Description and Major Businesses
Table 73. Sumitomo Chemicals Product Models, Descriptions and Specifications
Table 74. Sumitomo Chemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Sumitomo Chemicals Sales Value Proportion by Product in 2024
Table 76. Sumitomo Chemicals Sales Value Proportion by Application in 2024
Table 77. Sumitomo Chemicals Sales Value Proportion by Geographic Area in 2024
Table 78. Sumitomo Chemicals Pharmaceutical Grade Aluminum Hydroxide SWOT Analysis
Table 79. Sumitomo Chemicals Recent Developments
Table 80. Zibo Pengfeng Corporation Information
Table 81. Zibo Pengfeng Description and Major Businesses
Table 82. Zibo Pengfeng Product Models, Descriptions and Specifications
Table 83. Zibo Pengfeng Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Zibo Pengfeng Sales Value Proportion by Product in 2024
Table 85. Zibo Pengfeng Sales Value Proportion by Application in 2024
Table 86. Zibo Pengfeng Sales Value Proportion by Geographic Area in 2024
Table 87. Zibo Pengfeng Pharmaceutical Grade Aluminum Hydroxide SWOT Analysis
Table 88. Zibo Pengfeng Recent Developments
Table 89. Jianzhan Aluminium Corporation Information
Table 90. Jianzhan Aluminium Description and Major Businesses
Table 91. Jianzhan Aluminium Product Models, Descriptions and Specifications
Table 92. Jianzhan Aluminium Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Jianzhan Aluminium Sales Value Proportion by Product in 2024
Table 94. Jianzhan Aluminium Sales Value Proportion by Application in 2024
Table 95. Jianzhan Aluminium Sales Value Proportion by Geographic Area in 2024
Table 96. Jianzhan Aluminium Pharmaceutical Grade Aluminum Hydroxide SWOT Analysis
Table 97. Jianzhan Aluminium Recent Developments
Table 98. AL-TECH Corporation Information
Table 99. AL-TECH Description and Major Businesses
Table 100. AL-TECH Product Models, Descriptions and Specifications
Table 101. AL-TECH Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. AL-TECH Recent Developments
Table 103. Nippon Light Metal Corporation Information
Table 104. Nippon Light Metal Description and Major Businesses
Table 105. Nippon Light Metal Product Models, Descriptions and Specifications
Table 106. Nippon Light Metal Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. Nippon Light Metal Recent Developments
Table 108. PT INDONESIA CHEMICAL ALUMINA Corporation Information
Table 109. PT INDONESIA CHEMICAL ALUMINA Description and Major Businesses
Table 110. PT INDONESIA CHEMICAL ALUMINA Product Models, Descriptions and Specifications
Table 111. PT INDONESIA CHEMICAL ALUMINA Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. PT INDONESIA CHEMICAL ALUMINA Recent Developments
Table 113. Huber Corporation Information
Table 114. Huber Description and Major Businesses
Table 115. Huber Product Models, Descriptions and Specifications
Table 116. Huber Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 117. Huber Recent Developments
Table 118. Nabaltec Corporation Information
Table 119. Nabaltec Description and Major Businesses
Table 120. Nabaltec Product Models, Descriptions and Specifications
Table 121. Nabaltec Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 122. Nabaltec Recent Developments
Table 123. Inotal Aluminium Corporation Information
Table 124. Inotal Aluminium Description and Major Businesses
Table 125. Inotal Aluminium Product Models, Descriptions and Specifications
Table 126. Inotal Aluminium Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 127. Inotal Aluminium Recent Developments
Table 128. R.J. Marshall Corporation Information
Table 129. R.J. Marshall Description and Major Businesses
Table 130. R.J. Marshall Product Models, Descriptions and Specifications
Table 131. R.J. Marshall Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 132. R.J. Marshall Recent Developments
Table 133. Dadco Group Corporation Information
Table 134. Dadco Group Description and Major Businesses
Table 135. Dadco Group Product Models, Descriptions and Specifications
Table 136. Dadco Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 137. Dadco Group Recent Developments
Table 138. Alteo Corporation Information
Table 139. Alteo Description and Major Businesses
Table 140. Alteo Product Models, Descriptions and Specifications
Table 141. Alteo Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 142. Alteo Recent Developments
Table 143. Albemarle Corporation Information
Table 144. Albemarle Description and Major Businesses
Table 145. Albemarle Product Models, Descriptions and Specifications
Table 146. Albemarle Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 147. Albemarle Recent Developments
Table 148. Almatis Corporation Information
Table 149. Almatis Description and Major Businesses
Table 150. Almatis Product Models, Descriptions and Specifications
Table 151. Almatis Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 152. Almatis Recent Developments
Table 153. Showa Denko Corporation Information
Table 154. Showa Denko Description and Major Businesses
Table 155. Showa Denko Product Models, Descriptions and Specifications
Table 156. Showa Denko Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 157. Showa Denko Recent Developments
Table 158. Shandong Lvye Corporation Information
Table 159. Shandong Lvye Description and Major Businesses
Table 160. Shandong Lvye Product Models, Descriptions and Specifications
Table 161. Shandong Lvye Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 162. Shandong Lvye Recent Developments
Table 163. Luoyang Zhongchao Non-metallic Corporation Information
Table 164. Luoyang Zhongchao Non-metallic Description and Major Businesses
Table 165. Luoyang Zhongchao Non-metallic Product Models, Descriptions and Specifications
Table 166. Luoyang Zhongchao Non-metallic Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 167. Luoyang Zhongchao Non-metallic Recent Developments
Table 168. Zibo Peng Feng Aluminum Corporation Information
Table 169. Zibo Peng Feng Aluminum Description and Major Businesses
Table 170. Zibo Peng Feng Aluminum Product Models, Descriptions and Specifications
Table 171. Zibo Peng Feng Aluminum Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 172. Zibo Peng Feng Aluminum Recent Developments
Table 173. Shanxi Aluminum Big Plant Chemical Corporation Information
Table 174. Shanxi Aluminum Big Plant Chemical Description and Major Businesses
Table 175. Shanxi Aluminum Big Plant Chemical Product Models, Descriptions and Specifications
Table 176. Shanxi Aluminum Big Plant Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 177. Shanxi Aluminum Big Plant Chemical Recent Developments
Table 178. Zibo Hongjia Aluminum Corporation Information
Table 179. Zibo Hongjia Aluminum Description and Major Businesses
Table 180. Zibo Hongjia Aluminum Product Models, Descriptions and Specifications
Table 181. Zibo Hongjia Aluminum Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 182. Zibo Hongjia Aluminum Recent Developments
Table 183. Guangzhou Hengbang Chemical Corporation Information
Table 184. Guangzhou Hengbang Chemical Description and Major Businesses
Table 185. Guangzhou Hengbang Chemical Product Models, Descriptions and Specifications
Table 186. Guangzhou Hengbang Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 187. Guangzhou Hengbang Chemical Recent Developments
Table 188. Sichuan Chunfei Chemical Corporation Information
Table 189. Sichuan Chunfei Chemical Description and Major Businesses
Table 190. Sichuan Chunfei Chemical Product Models, Descriptions and Specifications
Table 191. Sichuan Chunfei Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 192. Sichuan Chunfei Chemical Recent Developments
Table 193. Key Raw Materials Distribution
Table 194. Raw Materials Key Suppliers
Table 195. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 196. Milestones in Production Technology Evolution
Table 197. Distributors List
Table 198. Market Trends and Market Evolution
Table 199. Market Drivers and Opportunities
Table 200. Market Challenges, Risks, and Restraints
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Pharmaceutical Grade Aluminum Hydroxide Product Picture
Figure 2. Global Pharmaceutical Grade Aluminum Hydroxide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Aluminum Hydroxide for Coating Product Picture
Figure 4. Aluminum Hydroxide for Injection Product Picture
Figure 5. Global Pharmaceutical Grade Aluminum Hydroxide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Antacid Medication
Figure 7. Anti-Gastric Ulcer Drugs
Figure 8. Others
Figure 9. Pharmaceutical Grade Aluminum Hydroxide Report Years Considered
Figure 10. Global Pharmaceutical Grade Aluminum Hydroxide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2031) & (US$ Million)
Figure 12. Global Pharmaceutical Grade Aluminum Hydroxide Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Pharmaceutical Grade Aluminum Hydroxide Revenue Market Share by Region (2020-2031)
Figure 14. Global Pharmaceutical Grade Aluminum Hydroxide Sales (2020-2031) & (Tons)
Figure 15. Global Pharmaceutical Grade Aluminum Hydroxide Sales (CAGR) by Region (2020-2031) (Tons)
Figure 16. Global Pharmaceutical Grade Aluminum Hydroxide Sales Market Share by Region (2020-2031)
Figure 17. Global Pharmaceutical Grade Aluminum Hydroxide Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 18. Global Pharmaceutical Grade Aluminum Hydroxide Production Trend by Region (2020-2031) (Tons)
Figure 19. Global Pharmaceutical Grade Aluminum Hydroxide Production Market Share by Region (2020-2031)
Figure 20. Production Capacity Enablers & Constraints
Figure 21. Pharmaceutical Grade Aluminum Hydroxide Production Growth Rate in North America (2020-2031) & (Tons)
Figure 22. Pharmaceutical Grade Aluminum Hydroxide Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 23. Pharmaceutical Grade Aluminum Hydroxide Production Growth Rate in China (2020-2031) & (Tons)
Figure 24. Pharmaceutical Grade Aluminum Hydroxide Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 25. Top 5 and Top 10 Manufacturers Pharmaceutical Grade Aluminum Hydroxide Sales Volume Market Share in 2024
Figure 26. Global Pharmaceutical Grade Aluminum Hydroxide Revenue Market Share Ranking (2024)
Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 28. Aluminum Hydroxide for Coating Revenue Market Share by Manufacturer in 2024
Figure 29. Aluminum Hydroxide for Injection Revenue Market Share by Manufacturer in 2024
Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 32. Global Pharmaceutical Grade Aluminum Hydroxide Sales Market Share by Type (2020-2031)
Figure 33. Global Pharmaceutical Grade Aluminum Hydroxide Revenue Market Share by Type (2020-2031)
Figure 34. Global Pharmaceutical Grade Aluminum Hydroxide Sales Market Share by Application (2020-2031)
Figure 35. Global Pharmaceutical Grade Aluminum Hydroxide Revenue Market Share by Application (2020-2031)
Figure 36. North America Pharmaceutical Grade Aluminum Hydroxide Sales YoY (2020-2031) & (Tons)
Figure 37. North America Pharmaceutical Grade Aluminum Hydroxide Revenue YoY (2020-2031) & (US$ Million)
Figure 38. North America Top 5 Manufacturers Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) in 2024
Figure 39. North America Pharmaceutical Grade Aluminum Hydroxide Sales Volume (Tons) by Type (2020- 2031)
Figure 40. North America Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 41. North America Pharmaceutical Grade Aluminum Hydroxide Sales Volume (Tons) by Application (2020-2031)
Figure 42. North America Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. US Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2031) & (US$ Million)
Figure 44. Canada Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2031) & (US$ Million)
Figure 45. Mexico Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2031) & (US$ Million)
Figure 46. Europe Pharmaceutical Grade Aluminum Hydroxide Sales YoY (2020-2031) & (Tons)
Figure 47. Europe Pharmaceutical Grade Aluminum Hydroxide Revenue YoY (2020-2031) & (US$ Million)
Figure 48. Europe Top 5 Manufacturers Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) in 2024
Figure 49. Europe Pharmaceutical Grade Aluminum Hydroxide Sales Volume (Tons) by Type (2020-2031)
Figure 50. Europe Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 51. Europe Pharmaceutical Grade Aluminum Hydroxide Sales Volume (Tons) by Application (2020-2031)
Figure 52. Europe Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 53. Germany Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2031) & (US$ Million)
Figure 54. France Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2031) & (US$ Million)
Figure 55. U.K. Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2031) & (US$ Million)
Figure 56. Italy Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2031) & (US$ Million)
Figure 57. Russia Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2031) & (US$ Million)
Figure 58. Asia-Pacific Pharmaceutical Grade Aluminum Hydroxide Sales YoY (2020-2031) & (Tons)
Figure 59. Asia-Pacific Pharmaceutical Grade Aluminum Hydroxide Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Top 8 Manufacturers Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) in 2024
Figure 61. Asia-Pacific Pharmaceutical Grade Aluminum Hydroxide Sales Volume (Tons) by Type (2020- 2031)
Figure 62. Asia-Pacific Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 63. Asia-Pacific Pharmaceutical Grade Aluminum Hydroxide Sales Volume (Tons) by Application (2020-2031)
Figure 64. Asia-Pacific Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 65. Indonesia Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2031) & (US$ Million)
Figure 66. Japan Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2031) & (US$ Million)
Figure 67. South Korea Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2031) & (US$ Million)
Figure 68. China Taiwan Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2031) & (US$ Million)
Figure 69. India Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2031) & (US$ Million)
Figure 70. Central and South America Pharmaceutical Grade Aluminum Hydroxide Sales YoY (2020-2031) & (Tons)
Figure 71. Central and South America Pharmaceutical Grade Aluminum Hydroxide Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Central and South America Top 5 Manufacturers Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) in 2024
Figure 73. Central and South America Pharmaceutical Grade Aluminum Hydroxide Sales Volume (Tons) by Type (2021-2031)
Figure 74. Central and South America Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Central and South America Pharmaceutical Grade Aluminum Hydroxide Sales Volume (Tons) by Application (2020-2031)
Figure 76. Central and South America Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. Brazil Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2025) & (US$ Million)
Figure 78. Argentina Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2025) & (US$ Million)
Figure 79. Middle East, and Africa Pharmaceutical Grade Aluminum Hydroxide Sales YoY (2020-2031) & (Tons)
Figure 80. Middle East and Africa Pharmaceutical Grade Aluminum Hydroxide Revenue YoY (2020-2031) & (US$ Million)
Figure 81. Middle East and Africa Top 5 Manufacturers Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) in 2024
Figure 82. Middle East and Africa Pharmaceutical Grade Aluminum Hydroxide Sales Volume (Tons) by Type (2021-2031)
Figure 83. South America Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 84. Middle East and Africa Pharmaceutical Grade Aluminum Hydroxide Sales Volume (Tons) by Application (2020-2031)
Figure 85. Middle East and Africa Pharmaceutical Grade Aluminum Hydroxide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 86. GCC Countries Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2025) & (US$ Million)
Figure 87. Turkey Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2025) & (US$ Million)
Figure 88. Egypt Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2025) & (US$ Million)
Figure 89. South Africa Pharmaceutical Grade Aluminum Hydroxide Revenue (2020-2025) & (US$ Million)
Figure 90. Pharmaceutical Grade Aluminum Hydroxide Industry Chain Mapping
Figure 91. Regional Pharmaceutical Grade Aluminum Hydroxide Manufacturing Base Distribution (%)
Figure 92. Pharmaceutical Grade Aluminum Hydroxide Production Process
Figure 93. Regional Pharmaceutical Grade Aluminum Hydroxide Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Pharmaceutical Grade Aluminum Hydroxide market?zhanKai
The top companies in the global Pharmaceutical Grade Aluminum Hydroxide market are CHALCO、KC Corp、Sumitomo Chemicals.
den_biaoTiZhungShi

Related Reports

Global Pharmaceutical Grade Aluminum Hydroxide Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-08-05

Pages: 191 Pages

Report ld: 4874824

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now